Sigyn Therapeutics (SIGY) EBIT (QoQ) (2017 - 2025)
Sigyn Therapeutics (SIGY) EBIT (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.67% |
| Jun 30, 2025 | 14.02% |
| Mar 31, 2025 | -14.24% |
| Dec 31, 2024 | 40.87% |
| Sep 30, 2024 | -34.12% |
| Jun 30, 2024 | 4.31% |
| Mar 31, 2024 | 12.17% |
| Dec 31, 2023 | -11.58% |
| Sep 30, 2023 | -11.99% |
| Jun 30, 2023 | -10.12% |
| Mar 31, 2023 | -10.53% |
| Dec 31, 2022 | 11.63% |
| Sep 30, 2022 | -0.16% |
| Jun 30, 2022 | 12.55% |
| Mar 31, 2022 | -3.10% |
| Dec 31, 2021 | -3.07% |
| Sep 30, 2021 | -29.77% |
| Jun 30, 2021 | -9.88% |
| Mar 31, 2021 | -16.70% |
| Dec 31, 2020 | -69.76% |